Site icon Fact.MR Blog

Market For Plasma Fractionation Is Anticipated To Surpass A CAGR Of 7% Through 2031

Plasma Fractionation Market

According to Fact.MR, the plasma fractionation market is expected to register a CAGR of more than 7% along with the market size being valued at US$ 38 Bn at the end of the 2021-2031 forecast period. Rising prevalence of infectious and chronic diseases is majorly spurring expansion of the market.

As per historical trends, between 2016 and 2020, demand for plasma fractionation surged at a CAGR of 5%, closing in at a valuation of US$ 19 Bn. The impact of COVID-19 has been tremendously huge on the plasma fractionation market. Increase in respiratory problems and blood disorders has led to patients opting for plasma fractionation. Technological advancements in the plasma fractionation sector has further propelled the growth of plasma fractionation.

Prominent manufacturers are expected to capitalize on the ever-growing prospects for treating neurological disorders. Statistics suggest that these disorders have affected 450 million globally. Thus, the neurology segment for plasma fractionation is expected to witness robust growth by registering a CAGR of 7.2%

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-

Key Segments Covered

Competitive Landscape

The plasma fractionation market consists of multiple players. Innovative product offerings and new product development are key growth strategies adopted by market players.


Exit mobile version